Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 |
Bendroflumethiazide
(Nadolol and Bendroflumethiazide) | [1] BENDROFLUMETHIAZIDE BENDROFLUMETHIAZIDE | [1] Bendroflumethiazide
Bendroflumethiazide
(Bendroflumethiazide) 💬
| [1] SLC12A3 SLC12A3 💬
| - | [1] 67 67 💬
|
| 2 |
Nadolol
(Nadolol and Bendroflumethiazide) | [1] Nadolol Nadolol | [1] Nadolol
Nadolol
💬
| [2] ADRB1 ADRB1,ADRB2 💬 | [11] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 💬
|